Atlas
statminds
Categorical GLM (Comparative Model)The underlying model family class (e.g. GLM, linear model, categorical matrix, log-linear).Parametric ReferenceStatistical methods that assume a specific probability distribution family (typically normal).12-stage workflow

Chi-Square Homogeneity

The engine for Proportional Comparison. This model audits whether multiple independent populations share the same distribution across categories, revealing if the 'Profile' of outcomes is uniform across groups.

Model familyCategorical GLM (Comparative Model)
Hypothesisomnibus
AliasesTest of Equal Proportions · Chi-Square Multi-Sample Test · Categorical Profile Comparison
G1
Profile Parity Audit
Determine if different treatment groups or demographics share the same 'Proportional Signature' for success or failure.
G2
Categorical Profile Mapping
Identify the specific group that deviates most from the shared population profile.
G3
Proportional Discovery
Quantify the magnitude of difference in categorical makeup between unrelated samples.
1

What is it?

Chi-Square Test of Homogeneity determines whether different populations share the exact same distribution of a single categorical variable.

2

When to use it

  • Multiple Populations: e.g. distribution of responses across 3 distinct regions.
  • Single Category Axis: Compare the categorical rates between the groups.
3

Core Idea

We test whether the proportions of categories are identical across groups:

P(Success | Group 1) = P(Success | Group 2)

It shares the exact same mathematical formulation as the independence test, but differs in experimental design (fixed margins for groups).

4

Hypotheses

H0: Proportions are equal across all populations (homogeneity).
Ha: Proportions differ significantly between groups.
5

How it works

  1. Separate samples from independent populations.
  2. Compute expected counts based on pooled rates.
  3. Calculate the standard X2 cell-residual summation.
  4. Determine p-value with df = (populations - 1) * (categories - 1).
6

Assumptions

📊 Cell Count: Expected counts in all cells should be >= 5.
👤 Independent Groups: Independent random sampling from each population.
7

Effect Size

Similar to independence, Cramér's V is utilized. For a 2x2 comparison, it corresponds to the difference in success rate proportions.

8

Quick Example

PopulationSuccessFailure
Group 16535
Group 24060
Interactive Sandbox

Homogeneity Live Laboratory

Vary success and failure counts for Group 1 and Group 2 to compare their percentage distributions dynamically.

Group 1 Success65
Group 1 Failure35
Group 2 Success40
Group 2 Failure60
Stacked Percentage Comparison BarsBlue = Success %, Orange = Failure %
100%50%Group 165%35%Group 240%60%
Calculations Output
MetricValue
Total Sample Size (N)200
Chi-Square Statistic (X2)12.5313
Degrees of Freedom (df)1
p-value0.0004
Homogeneity Verdict

Heterogeneous The categorical distribution differs significantly between populations (p = 0.0004). We reject the null hypothesis of homogeneity.

The 12-Stage Precision Workflow
01Uniformity Logic
Hypotheses
We test the Null (identical profiles) against the discovery of a significant 'Breaking of the Shared Proportions'.
02Independent Sampling
Assumptions
The ultimate prerequisite: each population must be sampled independently—ensuring that membership in one group doesn't influence the other.
03Cell Density Forensics
Diagnostics
Checking the expected frequencies in each group-category cell—ensuring the grid is robust enough for stable proportional discovery.
04focus
Comparing the Proportions of High/Med/Low responders across three distinct clinic sites implementing the FlowMotion protocol.
05Ordered Pivot
Alternatives
Knowing when to switch to Cochran-Armitage Trend Test if the categories have a natural ranking (e.g., Stage 1, 2, 3).
06The Comparative Strike
Significance
Calculating the total distance between the 'Shared Average Profile' and your 'Observed Group Profiles'—yielding the χ² statistic.
07Cramer's V
Effect Size
Interpreting V directly: a value of 0.3 indicates a robust and clinically meaningful shift in the proportional makeup between groups.
08Precision Target
Sample Size
Determining the N per group required to ensure that even subtle profile shifts reach the threshold of statistical authority.
09The Profile Statement
Reporting
Reporting the percentages clearly: 'The treatment group showed a significantly different response profile compared to control, χ²(df) = X.XX, p = .XXX.'
10Prop.Test Logic
Software
Executing 'prop.test' or 'chisq.test' on a matrix, ensuring the rows correctly represent the independent populations.
11focus
The fatal error of confusing Independence (one group, two variables) with Homogeneity (multiple groups, one variable).
12focus
Tracing the logic back to the expansion of contingency table forensics for clinical and epidemiological multi-group comparisons.
01Hypothesis test logic

Hypotheses

Pragmatic null and alternative hypotheses defined in mathematical notation.

A hypothesis is a question sharpened to a point. Ambiguity is the enemy of inference.
Logic Core
Null · H₀

H₀: All groups have the same distribution across categories (homogeneous proportions)

Alternative · Hₐ

Hₐ: At least one group has a different distribution (heterogeneous proportions)

Why it matters omnibus

Tests whether k independent groups have identical distributions on a categorical outcome variable. One margin (groups) is fixed by sampling design. Uses chi-square distribution with (r-1)(c-1) df.

02Model diagnostics

Assumptions

The core mathematical criteria needed to ensure that statistical testing remains unbiased and valid.

Build your analysis on rock, not sand. Verify the mathematical foundation before building the model.
Integrity Shield
6
Assumptions
0
Critical / High Severity
How to check
Quick
Verify study design: Are groups non-overlapping (e.g., different regions, treatment arms, time periods)? Check that sum of group sizes equals total N. Confirm no individual appears in multiple groups.
Rigorous
Review sampling frame for each group. Check for common participants across groups (linkage analysis). Verify temporal independence if groups are time-based. Examine residual plots for patterns suggesting dependence between groups.
If violated
Remove overlapping observations. For nested data (e.g., students within schools within districts), aggregate to highest independent level or use cluster-robust methods. Alternatives: Mixed-effects models for nested/hierarchical data, repeated measures ANOVA for within-subjects designs, McNemar's test or marginal homogeneity test for matched groups, GEE for correlated groups.
mcnemargee
How to check
Quick
Calculate expected frequencies: E_ij = (n_i × n_j) / N where n_i is group i size, n_j is category j total across groups, N is grand total. Count cells with E < 5, compute percentage.
Rigorous
Monte Carlo simulation: generate 10,000 contingency tables under H₀ with actual group sizes and overall category distribution. Apply chi-square test to each, check if rejection rate ≈ α. If inflated (e.g., 7-8% when α=5%), assumptions violated.
If violated
Combine adjacent/similar outcome categories (e.g., merge 'strongly agree' + 'agree'). Increase sample sizes in groups with low counts. Combine groups if conceptually appropriate (e.g., merge two treatment doses). Alternatives: Fisher-Freeman-Halton exact test (generalization of Fisher's exact for r×c tables), permutation test, G-test (log-likelihood ratio), Bayesian multinomial-Dirichlet model for small samples.
fisher exact
How to check
Quick
For each group, verify sum of category frequencies equals group size. Check for 'Other' or 'Unknown' categories exceeding 5-10% of sample. Review coding scheme for ambiguous cases.
Rigorous
Inter-rater reliability: have independent coders classify subset of observations, calculate Cohen's kappa. κ > 0.80 suggests clear category definitions. Examine raw data for patterns in missing/ambiguous cases.
If violated
Redefine categories to ensure mutual exclusivity. Create explicit 'Mixed' or 'Multiple' category if outcomes genuinely overlap (but interpret cautiously). Remove observations with missing outcome data and report exclusions. Alternatives: Multinomial logistic regression allows modeling of overlapping risk factors. Latent class analysis for fuzzy category memberships. Multiple imputation if missingness is random.
logistic regression
How to check
Quick
Review study protocol: Were group sizes predetermined (homogeneity)? Or did you sample N individuals and classify on two variables post-hoc (independence)? Fixed group sizes → homogeneity framework.
Rigorous
Examine study documentation/pre-registration. Check randomization logs for experimental studies. For observational studies, verify whether groups were sampled separately vs. stratified from single population.
If violated
If both margins are random (sampled from one population, classified on two variables), reframe as test of independence rather than homogeneity. Hypothesis changes but test statistic remains the same. Alternatives: Bayesian methods can accommodate different sampling schemes through likelihood specification. Log-linear models explicitly model sampling scheme (Poisson, multinomial, product-multinomial).
How to check
Quick
Calculate n_i / k for each group i, where k is number of outcome categories. Aim for ratio ≥ 5-10 per group. Check for extreme imbalance: max(n_i) / min(n_i) should be < 5-10.
Rigorous
Power analysis using pwr.chisq.test() in R with smallest group size. For imbalanced designs, simulate power via Monte Carlo with actual group sizes and expected effect size. Check if power < 0.5 in smallest group.
If violated
Increase sample size in small groups through additional recruitment. Combine small groups if conceptually justifiable. Reduce number of outcome categories. Use balanced sampling if feasible. Alternatives: Exact tests for small samples. Bayesian methods with informative priors to stabilize estimates in small groups. Poisson regression if group sizes reflect natural frequencies.
poisson regression
How to check
Quick
Review data collection procedures for each group. Verify same questionnaire version, response options, and coding scheme used across groups. Check for systematic differences in measurement context (e.g., different languages, modes).
Rigorous
Measurement invariance testing: use multi-group confirmatory factor analysis to test whether outcome categories have equivalent meaning across groups. Differential item functioning (DIF) analysis if groups differ on theoretically relevant dimensions.
If violated
Harmonize categories: map different response formats to common scale (e.g., collapse 7-point to 5-point). Use validated crosswalk tables if different instruments used. Restrict analysis to common items/categories. Alternatives: Item response theory (IRT) models to account for differential item functioning. Ordinal regression with group interactions to test differential category thresholds. Report descriptive results only if measurement non-comparable.
03Residual Forensics

Diagnostics

Checking residual plots and indices to examine model deviations and ensure standard error integrity.

Trust, but verify. The outliers often hold more truth than the averages.
System Health
Essential checks
  1. Calculate and verify expected frequencies (≥80% cells with E≥5)
  2. Compute standardized residuals to identify which group-category combinations differ
  3. Check that group sample sizes match study design (fixed margins)
  4. Examine marginal distributions to understand overall category frequencies
  5. Verify total frequencies: sum across groups for each category should equal category total
Recommended checks
  1. Create mosaic plot showing group distributions with residual shading
  2. Plot group-specific proportions with confidence intervals for each category
  3. Calculate and compare within-group category proportions (column percentages)
  4. Conduct pairwise group comparisons with Bonferroni correction
  5. Test for dose-response or ordered trend if groups represent ordinal factor (e.g., dosage levels)
  6. Examine Pearson vs. adjusted standardized residuals for outlier cells
  7. Compare chi-square test of homogeneity with test of independence on same data
  8. Create stacked or grouped bar charts for visual comparison of distributions
  9. Assess effect size heterogeneity: which groups differ most?
  10. Sensitivity analysis: exclude smallest group to check stability of results
04Live Instances

Applied Minds

Review concrete study examples, data layout guidelines, and copy executable syntax scripts.

Theory is the map. Practice is the terrain. Simulation bridges the gap.
Applied Wisdom
Example 01

Comparing 3 Therapies Across 3 Recovery Levels

Clinical trial comparing three treatment approaches (Cognitive-Behavioral Therapy, Medication, Combined) on recovery outcomes (Full Recovery, Partial Recovery, No Recovery). Fixed sample sizes per treatment group: n=80 per group, total N=240. Includes comprehensive diagnostics, effect sizes with bootstrap CIs, pairwise comparisons, and 6 visualizations.

05Tactical Pivots

Alternatives

Structured fallback pathways for choosing alternative tests when normality or slopes requirements fail.

When the path is blocked, pivot. Rigor is not rigidity; it is the intelligent adaptation to reality.
Adaptive Strategy
Measurement Precision Ladder Ideal · Independent Nominal Groups
Ratio
Consider ANOVA or T-Tests if the outcome is continuous. Categorical comparison ignores raw-score magnitude.
Precision Loss
Ordinal
Pivot to Jonckheere-Terpstra if the populations follow a natural order (e.g., Dose 1, 2, 3).
Threshold Loss
Nominal
Maintain Homogeneity logic. The elite standard for comparing categorical profiles across independent groups.
Peak Signal
Temporal Trajectory Audit Static Profile Comparison
Static Populations
Cross-sectional audit.
Stay with Chi-Square Homogeneity. Determine if groups share the same proportional DNA.
Longitudinal Profiles
Trajectory clustering.
Pivot to Marginal Homogeneity tests (Stuart-Maxwell) or GEE to model how group profiles shift over time.
Adaptive Technical Safeguards · adaptive safeguards
sparsity detected
  • Fisher-Freeman-Halton Test — Exact probability for tables larger than 2x2 with sparse cell counts.
  • Monte Carlo χ² — Resample the null distribution to protect significance in high-D categorical grids.
highly correlated categories
  • Binary Logistic Strike — Collapse categories into 'Success/Failure' to maximize comparative power.
06Adjusted Comparisons

Post-hoc

Group mean comparisons and correction controls (e.g. Tukey HSD, Bonferroni) to protect against Family-Wise Error Rates.

The omnibus test opens the door; post-hoc analysis explores the room.
Forensic Detail
Adjusted Comparisons

Post-hoc pairwise tests defined for this model.

Correction methods
Pairwise chi-square tests with Bonferroni correction: compare k groups requires k(k-1)/2 tests, use α_adjusted = α / n_comparisonsAdjusted standardized residuals: |residual| > 2 for individual cells indicates p < .05Column proportion tests with Holm-Bonferroni or FDR correctionSimultaneous confidence intervals for proportion differencesPartition chi-square if groups have natural ordering (trend vs. departure)
Interpretation Guidelines

No specific guidelines provided.

07Standardized scale impact

Effect Size

Understanding effect sizes (e.g., Cohen's d, Partial Eta-Squared) and clinical impact benchmarks.

Significance is noise. Magnitude is the signal. Measure the impact, not just the probability.
Impact Magnitude
formula

V = sqrt(χ² / (n × min(r-1, c-1)))

interpretation df1

{"small":0.07,"medium":0.21,"large":0.35,"note":"For min(r-1, c-1) = 1"}

interpretation df2

{"small":0.06,"medium":0.17,"large":0.29,"note":"For min(r-1, c-1) = 2"}

note

Standardized effect size ranging 0-1. Adjusts for table dimensions. Use bootstrap for confidence intervals.

confidence intervals

Bootstrap resampling (1500+ iterations) for 95% CI

formula

w = sqrt(sum((p_obs - p_exp)² / p_exp))

small

0.1

medium

0.3

large

0.5

note

Measures overall discrepancy from homogeneity hypothesis. Used in power analysis.

Recommended Metric: Cramér's V with bootstrap 95% CI
Small
0.2
Medium
0.5
Large
0.8
0.50
Cramér's V with bootstrap 95% CI
Recommended Measure
3
Available Metrics
ReportUse Cramér's V with bootstrap 95% CI to represent clinical impact magnitude.
08Statistical Power

Sample Size

Guidelines for minimum sample requirements and power analysis parameters.

An underpowered study is an ethical failure. Respect the data by collecting enough of it.
Power Protocol
Floor Requirements

The 'Profile Stability' Mandate: A minimum of 20 participants per population group is essential. Proportional signatures collapse if the denominator is too shallow.

Effect SizeParametersRequired n
Small Effectw=0.10 (Small)n ≈ 964 total
Medium Effectw=0.30 (Medium)n ≈ 108 total
Large Effectw=0.50 (Large)n ≈ 39 total
Key considerations

The 'Yield' Penalty: If one category is extremely rare across all populations, the model will 'choke'. Recruit for total N but ensure the categories of interest are adequately represented.

G*Power StrategyBenchmark: χ² tests → Goodness-of-fit: Contingency tables. Parameters: Effect size w, α = .05, Power = .80, df = 2 (for 3 populations). Note: Power decreases as more populations are added to the audit.
09APA narrative blueprint

Reporting

How to compile statistical results into publication prose matching APA and journal style guides.

Data does not speak for itself. It requires a translator. Be clear, be precise, be honest.
Narrative Arc
Worked APA paragraph example
A chi-square test of homogeneity was performed to compare recovery outcome distributions across three treatment approaches (CBT, Medication, Combined therapy) in a randomized clinical trial (N = 240, n = 80 per group). All expected cell frequencies exceeded 14.0, satisfying assumptions for valid chi-square approximation. The analysis revealed significant heterogeneity in recovery distributions across treatments, χ²(4, N = 240) = 11.85, p = .018, Cramér's V = .157, 95% CI [.068, .251], indicating a small to medium effect. Post-hoc examination of adjusted standardized residuals showed that Combined therapy yielded significantly more Full Recovery outcomes (43.8% vs. expected 37.5%, residual = 2.1, p < .05) and fewer No Recovery outcomes (12.5% vs. expected 18.8%, residual = -2.3, p < .05) compared to expectation under homogeneity. Pairwise comparisons with Bonferroni correction (α = .017) revealed significant differences between Combined therapy and Medication (χ²(2) = 9.12, p = .010, V = .239) but not between CBT and Medication (χ²(2) = 2.84, p = .242). These findings suggest that Combined therapy offers a more favorable outcome profile, with higher rates of full recovery and lower rates of treatment failure.
Reusable template

A chi-square test of homogeneity was conducted to compare outcome variable distributions across k groups. The test revealed significant heterogeneity, χ²(df, N = n) = X.XX, p = .XXX, Cramér's V = .XX, 95% CI .XX, .XX. Post-hoc pairwise comparisons with Bonferroni correction (α = .XX) showed specific results. Examination of adjusted standardized residuals indicated specific group-category combinations.

10Exhibit Builder

Manuscript Lab

Copy standard summary tables and forensic reporting grids to outline analysis details.

Table 1: Chi-Square Test of Homogeneity for Satisfaction across Hospitals
RegionSatisfiedNeutralDissatisfiedχ²p
Hospital A80 (80%)15 (15%)5 (5%)15.42< .001
Hospital B60 (60%)20 (20%)20 (20%)——
Hospital C50 (50%)30 (30%)20 (20%)——
Note. N = 300. Testing if the satisfaction distribution is identical across regions.
Hospital A (80%)Identifies the Outlier. Hospital A has a significantly higher satisfaction profile than B or C, driving the significant Chi-Square result.
p < .001Confirms Regional Disparity. The differences in patient experience across these three locations are not due to random variation.
Header glossary

The 'Equality' Audit. Tests if the categorical profiles of separate groups are identical. Unlike 'Independence', we fix the group totals in advance.

The Discrepancy Multiplier. Measures the total distance between the observed distributions and the 'average' distribution of all groups combined.

11Algorithmic Logic

Command Center

Syntax libraries and function parameters for executing calculations in stats packages.

Code is the modern laboratory. Clean execution ensures reproducible discovery.
Execution Engine
# 1. Execute Homogeneity Test
results <- chisq.test(table(df$hospital, df$satisfaction))
print(results)

# 2. Extract Standardized Residuals
# (Helps find which cells drive the significance)
results$residuals
Library stack
R
statsvcd
Python
scipy.stats
Elite Forensic Strike

Homogeneity and Independence use the same math but different logic. Use Homogeneity when you have pre-defined groups (e.g., Treatment vs Control) and want to compare their profiles.

# Extract effect size for multi-group comparison
lsr::cramersV(table(df$hospital, df$satisfaction))
12The Over-adjustment Trap

Common Mistakes

Analytical caveats and corrections to maintain modeling integrity.

Wisdom is learning from the failures of others. Anticipate the error before it occurs.
Defensive Logic
Why it's wrong
The two tests use identical formulas but differ in sampling scheme and interpretation. Independence: sample N from one population, classify on two variables (both margins random). Homogeneity: sample fixed n₁, n₂,... from k populations, measure distribution on outcome (one margin fixed). Using wrong framework leads to incorrect inference about what the test demonstrates.
The correction
Identify sampling scheme: Did you fix group sizes in advance (homogeneity)? Or sample from one population and classify post-hoc (independence)? Homogeneity asks: 'Do these k groups have the same distribution?' Independence asks: 'Are these two variables associated?' Report appropriate test name. Example: 'A chi-square test of homogeneity compared party affiliation distributions across three age groups (n₁=150, n₂=175, n₃=175, fixed by stratified sampling).' vs. 'A chi-square test of independence examined association between age and party among 500 randomly sampled voters.'
Why it's wrong
Significant overall test (p < .05) indicates heterogeneity exists but doesn't specify which groups differ or which outcome categories drive differences. Stopping at omnibus test is like ANOVA without post-hoc comparisons—you know groups differ but not how. This misses substantive insights and reduces practical utility.
The correction
Always follow significant homogeneity test with: (1) Pairwise group comparisons using Bonferroni correction (α_adj = α/n_comparisons), and (2) Examination of adjusted standardized residuals (|r| > 2 indicates significant cell). Report: 'Post-hoc pairwise comparisons (Bonferroni α=.017) showed Combined therapy differed significantly from Medication (χ²(2)=9.12, p=.010, V=.24) but not from CBT (χ²(2)=3.45, p=.178). Adjusted residuals revealed Combined therapy had excess Full Recovery (r=2.3) and deficit No Recovery (r=-2.1).'
Why it's wrong
Power in homogeneity test is determined primarily by smallest group. With n₁=200, n₂=180, n₃=25, power ~30% despite total N=405 because n₃=25 is inadequate. Analysts often focus on total N without recognizing that imbalance cripples power. Even significant result may miss important differences in small groups.
The correction
Before analysis, check minimum group size: n_min / k (where k=outcome categories) should be ≥10. If imbalanced, report power based on smallest group: 'With n_min=25 across 4 categories, power to detect medium effect (V=.17) is only 35%. Results should be interpreted cautiously.' Consider oversampling small groups, combining groups if conceptually appropriate, or using weighted analysis. Report: 'Group sizes ranged from 25 to 200. Power analysis indicated 80% power for largest group but only 35% for smallest, limiting ability to detect heterogeneity.'
Why it's wrong
Failure to reject H₀ (p ≥ .05) does not prove homogeneity—it may reflect low power due to small samples, many categories, or weak effects. Analysts often interpret p=.12 as 'groups are the same' when data may simply be insufficient to detect differences. This is 'absence of evidence is not evidence of absence' fallacy.
The correction
When test is non-significant, conduct post-hoc power analysis to assess whether sample was adequate to detect meaningful effects. Use pwr.chisq.test() with observed effect size and actual N. If power < 60%, acknowledge limitation. Report: 'Test was non-significant (χ²(4)=7.3, p=.121, V=.12), suggesting homogeneity. However, post-hoc power analysis indicated only 55% power to detect this effect, so results are inconclusive.' Alternatively: 'With 85% power, non-significant result (p=.28, V=.08) provides evidence for homogeneity within measurement precision.'
Why it's wrong
Apparent heterogeneity may reflect measurement artifacts rather than true distribution differences. Example: Group A uses 5-point recovery scale, Group B uses 3-point scale; or different time windows for outcome assessment (6 months vs. 12 months). Comparing non-comparable categories yields meaningless results.
The correction
Before analysis, verify: (1) identical response options across groups, (2) same time frame for assessment, (3) equivalent measurement instruments, (4) consistent coding schemes. If groups differ, harmonize categories (e.g., collapse 7-point to match 5-point scale) or conduct measurement invariance testing. Report: 'Outcome categories were harmonized across sites: initial 7-point scale (Sites A,B) collapsed to match 5-point scale (Site C) using validated crosswalk [cite], ensuring comparable definitions.' If non-comparable, report descriptively only.
Why it's wrong
Reporting only χ² and p-value without showing actual outcome distributions within each group makes results uninterpretable. Readers cannot assess practical significance, clinical relevance, or direction of differences. A significant test tells you groups differ, but not how they differ.
The correction
Always report within-group proportions (column percentages): proportion in each outcome category for each group. Create table or stacked bar chart showing distributions. Report: 'Full recovery rates were 43.8% (Combined), 31.3% (Medication), and 43.8% (CBT). No recovery rates were 12.5% (Combined), 25.0% (Medication), and 18.8% (CBT). Combined therapy showed most favorable profile with highest full recovery and lowest failure rate.' Include confidence intervals for proportions if possible.
Why it's wrong
When groups represent ordered factor (e.g., low/medium/high dose; young/middle/old age), standard omnibus test treats groups as nominal, ignoring ordinal information. This loses power to detect dose-response or monotonic trends. Test dilutes signal across all (r-1)(c-1) df when primary interest is often linear trend (c-1 df).
The correction
For ordered groups, partition chi-square into linear trend and departure from linearity: χ²_total = χ²_trend + χ²_departure. Use Cochran-Armitage test for trend in proportions (if binary outcome) or ordinal trend tests for multi-category outcomes. Report: 'Linear trend analysis showed significant dose-response in recovery rates (χ²_trend(2)=18.3, p<.001), with no significant departure from linearity (χ²_departure(6)=4.2, p=.65). Higher doses associated with better outcomes in monotonic fashion.' This tests specific hypothesis with greater power.
Why it's wrong
Testing homogeneity across multiple outcome variables or subgroups without correction inflates family-wise error rate. Example: testing 5 outcomes across 3 treatments yields 5 tests; with α=.05, probability of ≥1 false positive is 23%. Selective reporting of 'significant' outcomes is p-hacking.
The correction
Pre-specify primary outcome(s) in study protocol. For multiple outcomes, apply family-wise error correction: Bonferroni (α_adj = α/n_tests), Holm-Bonferroni (sequential), or FDR (Benjamini-Hochberg). Report all tests, not just significant ones. Example: 'We tested homogeneity for 4 outcomes (recovery, satisfaction, symptoms, function) using Bonferroni-corrected α=.0125. Only recovery showed significant heterogeneity (p=.008); other outcomes were non-significant (p=.034-.18).' Alternatively, use multivariate approach (MANOVA) if outcomes correlated.
13Academic Lineage

References

Scholarly lineage and citation keys grounding the statistical framework.

We stand on the shoulders of giants. Honor the source of the method.
Academic Lineage
[1]
[2]
[3]
[4]
[5]
[6]
Proportions are the DNA of categorical data. If they don't match between groups, you have found a structural difference in the population response. Unpack it with precision.
The Interpretive Rigor Directive
statminds · Chi-SquareMind reference · v2.2 · updated 2026-01-1715 of 15 sections